Nicholas Ollberding
Concepts (300)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Non-Hodgkin | 10 | 2015 | 244 | 3.000 |
Why?
| Diet | 16 | 2017 | 373 | 2.590 |
Why?
| Feeding Behavior | 7 | 2016 | 269 | 2.190 |
Why?
| Vegetables | 3 | 2013 | 36 | 1.250 |
Why?
| Fruit | 3 | 2013 | 68 | 1.220 |
Why?
| Postmenopause | 4 | 2013 | 88 | 1.210 |
Why?
| Ethnic Groups | 8 | 2015 | 411 | 1.160 |
Why?
| Colorectal Neoplasms | 5 | 2016 | 770 | 1.130 |
Why?
| Nutritional Status | 2 | 2014 | 72 | 1.120 |
Why?
| Health Behavior | 3 | 2011 | 163 | 0.960 |
Why?
| Cardiopulmonary Bypass | 1 | 2020 | 147 | 0.880 |
Why?
| Cerebrovascular Circulation | 1 | 2020 | 182 | 0.850 |
Why?
| Hispanic Americans | 6 | 2016 | 334 | 0.830 |
Why?
| Case-Control Studies | 14 | 2019 | 1645 | 0.830 |
Why?
| Cohort Studies | 16 | 2016 | 2328 | 0.820 |
Why?
| Risk Factors | 18 | 2015 | 4731 | 0.740 |
Why?
| European Continental Ancestry Group | 7 | 2016 | 998 | 0.710 |
Why?
| Female | 49 | 2020 | 39738 | 0.690 |
Why?
| Urine | 1 | 2016 | 102 | 0.690 |
Why?
| Meat Products | 2 | 2012 | 3 | 0.680 |
Why?
| Aged | 29 | 2019 | 16344 | 0.680 |
Why?
| C-Reactive Protein | 2 | 2014 | 156 | 0.670 |
Why?
| Premature Birth | 1 | 2016 | 73 | 0.670 |
Why?
| Pediatrics | 6 | 2019 | 313 | 0.660 |
Why?
| Soy Foods | 2 | 2011 | 3 | 0.660 |
Why?
| Food | 2 | 2015 | 75 | 0.660 |
Why?
| Calcium, Dietary | 1 | 2015 | 67 | 0.640 |
Why?
| Adolescent Nutritional Physiological Phenomena | 1 | 2014 | 3 | 0.630 |
Why?
| Child Nutritional Physiological Phenomena | 1 | 2014 | 12 | 0.630 |
Why?
| Male | 42 | 2020 | 37354 | 0.600 |
Why?
| Leptin | 2 | 2014 | 99 | 0.580 |
Why?
| Middle Aged | 29 | 2019 | 22879 | 0.580 |
Why?
| Energy Intake | 5 | 2017 | 80 | 0.580 |
Why?
| Carotenoids | 2 | 2013 | 19 | 0.570 |
Why?
| Humans | 53 | 2020 | 72293 | 0.570 |
Why?
| Adiponectin | 1 | 2013 | 27 | 0.570 |
Why?
| Phytanic Acid | 1 | 2012 | 2 | 0.560 |
Why?
| Hawaii | 10 | 2016 | 24 | 0.550 |
Why?
| Smoking | 3 | 2013 | 526 | 0.540 |
Why?
| Heart Defects, Congenital | 3 | 2020 | 308 | 0.540 |
Why?
| Heterocyclic Compounds | 1 | 2012 | 15 | 0.540 |
Why?
| Food Supply | 1 | 2012 | 15 | 0.540 |
Why?
| Amines | 1 | 2012 | 25 | 0.530 |
Why?
| Somatomedins | 1 | 2012 | 28 | 0.530 |
Why?
| Phytoestrogens | 1 | 2011 | 2 | 0.530 |
Why?
| Soybeans | 1 | 2011 | 9 | 0.530 |
Why?
| Isoflavones | 1 | 2011 | 13 | 0.530 |
Why?
| Fabaceae | 1 | 2011 | 22 | 0.520 |
Why?
| Growth Inhibitors | 1 | 2011 | 47 | 0.520 |
Why?
| African Continental Ancestry Group | 1 | 2015 | 521 | 0.510 |
Why?
| Curriculum | 4 | 2019 | 386 | 0.490 |
Why?
| Food Labeling | 1 | 2010 | 8 | 0.480 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 445 | 0.470 |
Why?
| Health Status Disparities | 2 | 2014 | 120 | 0.460 |
Why?
| Communication | 3 | 2018 | 355 | 0.450 |
Why?
| Endometrial Neoplasms | 1 | 2011 | 153 | 0.450 |
Why?
| Proportional Hazards Models | 8 | 2016 | 781 | 0.420 |
Why?
| Nutrition Surveys | 3 | 2014 | 76 | 0.400 |
Why?
| California | 6 | 2016 | 125 | 0.390 |
Why?
| Adult | 21 | 2019 | 23156 | 0.390 |
Why?
| Infant Care | 2 | 2017 | 7 | 0.380 |
Why?
| Blood Glucose | 1 | 2012 | 820 | 0.380 |
Why?
| Diet Records | 3 | 2017 | 19 | 0.370 |
Why?
| Cross-Sectional Studies | 5 | 2016 | 1126 | 0.360 |
Why?
| Young Adult | 12 | 2019 | 4996 | 0.360 |
Why?
| Nutrition Assessment | 4 | 2016 | 22 | 0.350 |
Why?
| Obesity | 4 | 2015 | 836 | 0.350 |
Why?
| Milk, Human | 2 | 2016 | 41 | 0.350 |
Why?
| Education, Medical, Graduate | 3 | 2019 | 278 | 0.350 |
Why?
| Insulin | 1 | 2012 | 1098 | 0.350 |
Why?
| Adolescent | 10 | 2019 | 8076 | 0.340 |
Why?
| Asian Americans | 5 | 2016 | 98 | 0.340 |
Why?
| Breast Neoplasms | 3 | 2013 | 2496 | 0.330 |
Why?
| Body Mass Index | 6 | 2016 | 683 | 0.320 |
Why?
| United States | 9 | 2017 | 5310 | 0.320 |
Why?
| Oceanic Ancestry Group | 4 | 2014 | 39 | 0.310 |
Why?
| Prospective Studies | 9 | 2020 | 3417 | 0.310 |
Why?
| Cognition | 2 | 2020 | 442 | 0.310 |
Why?
| Fatty Acids | 2 | 2016 | 129 | 0.300 |
Why?
| Heart Ventricles | 2 | 2020 | 674 | 0.290 |
Why?
| Influenza, Human | 2 | 2017 | 342 | 0.290 |
Why?
| Follow-Up Studies | 7 | 2020 | 3431 | 0.290 |
Why?
| Lymphoma, Mantle-Cell | 2 | 2013 | 24 | 0.290 |
Why?
| Reproducibility of Results | 5 | 2019 | 2435 | 0.290 |
Why?
| Infant | 5 | 2020 | 2744 | 0.280 |
Why?
| Patient Compliance | 2 | 2017 | 221 | 0.270 |
Why?
| Mental Recall | 2 | 2015 | 96 | 0.260 |
Why?
| Linear Models | 2 | 2014 | 406 | 0.260 |
Why?
| Survivors | 2 | 2015 | 159 | 0.260 |
Why?
| Logistic Models | 4 | 2013 | 1067 | 0.250 |
Why?
| Infant, Newborn | 5 | 2020 | 2092 | 0.250 |
Why?
| Blood Gas Analysis | 1 | 2020 | 38 | 0.240 |
Why?
| Analysis of Variance | 2 | 2014 | 919 | 0.240 |
Why?
| Incidence | 4 | 2014 | 1438 | 0.230 |
Why?
| Life Style | 2 | 2011 | 167 | 0.230 |
Why?
| Longitudinal Studies | 3 | 2013 | 833 | 0.230 |
Why?
| Child | 5 | 2019 | 5795 | 0.230 |
Why?
| Asymptomatic Diseases | 1 | 2020 | 34 | 0.220 |
Why?
| Cardiac-Gated Imaging Techniques | 1 | 2019 | 21 | 0.220 |
Why?
| Patient Simulation | 1 | 2019 | 41 | 0.220 |
Why?
| Norwood Procedures | 1 | 2019 | 24 | 0.220 |
Why?
| Carbon Dioxide | 1 | 2020 | 190 | 0.220 |
Why?
| Retrospective Studies | 6 | 2020 | 6116 | 0.210 |
Why?
| Self Report | 2 | 2017 | 215 | 0.210 |
Why?
| RNA, Ribosomal, 16S | 2 | 2016 | 208 | 0.210 |
Why?
| Parents | 2 | 2018 | 218 | 0.210 |
Why?
| Papillomavirus Infections | 2 | 2017 | 133 | 0.210 |
Why?
| Sleep Apnea Syndromes | 1 | 2020 | 112 | 0.210 |
Why?
| Aortic Diseases | 1 | 2019 | 103 | 0.210 |
Why?
| Motor Activity | 2 | 2012 | 325 | 0.200 |
Why?
| Influenza Vaccines | 2 | 2017 | 168 | 0.200 |
Why?
| Aged, 80 and over | 7 | 2019 | 5876 | 0.200 |
Why?
| Professional-Family Relations | 1 | 2018 | 46 | 0.200 |
Why?
| Aortic Valve Stenosis | 1 | 2019 | 100 | 0.200 |
Why?
| Aorta | 1 | 2019 | 261 | 0.200 |
Why?
| Professional Competence | 1 | 2018 | 70 | 0.200 |
Why?
| Risk Assessment | 4 | 2017 | 2007 | 0.200 |
Why?
| Patient Discharge | 1 | 2019 | 171 | 0.190 |
Why?
| Coronary Vessels | 1 | 2019 | 170 | 0.190 |
Why?
| Aortic Valve | 1 | 2019 | 160 | 0.190 |
Why?
| Books | 1 | 2017 | 3 | 0.190 |
Why?
| Learning | 2 | 2019 | 223 | 0.190 |
Why?
| Calcinosis | 1 | 2019 | 240 | 0.190 |
Why?
| Heart Rate | 1 | 2020 | 464 | 0.190 |
Why?
| Papillomavirus Vaccines | 1 | 2017 | 25 | 0.190 |
Why?
| Pamphlets | 1 | 2017 | 13 | 0.190 |
Why?
| Extracellular Matrix | 1 | 2019 | 220 | 0.190 |
Why?
| Office Visits | 1 | 2017 | 30 | 0.190 |
Why?
| Sudden Infant Death | 1 | 2017 | 25 | 0.190 |
Why?
| Neoplasms | 1 | 2011 | 2260 | 0.180 |
Why?
| Magnetic Resonance Angiography | 1 | 2019 | 214 | 0.180 |
Why?
| Diet, Mediterranean | 1 | 2016 | 3 | 0.180 |
Why?
| Vulnerable Populations | 1 | 2017 | 59 | 0.180 |
Why?
| Meat | 2 | 2016 | 24 | 0.180 |
Why?
| Lactation | 1 | 2016 | 39 | 0.180 |
Why?
| Preventive Health Services | 1 | 2017 | 44 | 0.180 |
Why?
| Child Health Services | 1 | 2017 | 48 | 0.180 |
Why?
| Electrocardiography | 1 | 2019 | 472 | 0.180 |
Why?
| Risk | 3 | 2017 | 654 | 0.180 |
Why?
| Dietary Fats | 3 | 2013 | 141 | 0.180 |
Why?
| Cervical Intraepithelial Neoplasia | 1 | 2016 | 14 | 0.180 |
Why?
| Trisaccharides | 1 | 2015 | 13 | 0.180 |
Why?
| Mothers | 1 | 2017 | 113 | 0.170 |
Why?
| Interviews as Topic | 1 | 2017 | 307 | 0.170 |
Why?
| Short Bowel Syndrome | 1 | 2015 | 28 | 0.170 |
Why?
| Cervix Uteri | 1 | 2016 | 65 | 0.170 |
Why?
| Shellfish | 1 | 2015 | 5 | 0.170 |
Why?
| Seafood | 1 | 2015 | 9 | 0.170 |
Why?
| Health Promotion | 1 | 2017 | 145 | 0.170 |
Why?
| Mortality | 1 | 2016 | 124 | 0.170 |
Why?
| Child Development | 1 | 2016 | 127 | 0.160 |
Why?
| African Americans | 5 | 2016 | 954 | 0.160 |
Why?
| Imaging, Three-Dimensional | 1 | 2019 | 541 | 0.160 |
Why?
| Internet | 1 | 2017 | 283 | 0.160 |
Why?
| SEER Program | 2 | 2013 | 170 | 0.160 |
Why?
| Overweight | 1 | 2015 | 100 | 0.160 |
Why?
| Dietary Fiber | 2 | 2013 | 35 | 0.150 |
Why?
| Adipokines | 1 | 2014 | 21 | 0.150 |
Why?
| Tocopherols | 1 | 2013 | 6 | 0.150 |
Why?
| Hospitalization | 1 | 2019 | 637 | 0.150 |
Why?
| Body Weight | 1 | 2015 | 437 | 0.150 |
Why?
| Uterine Cervical Neoplasms | 1 | 2016 | 213 | 0.150 |
Why?
| Echocardiography | 1 | 2019 | 742 | 0.150 |
Why?
| Quality Improvement | 1 | 2017 | 291 | 0.150 |
Why?
| Bone Density | 1 | 2015 | 193 | 0.150 |
Why?
| Ohio | 3 | 2018 | 29 | 0.150 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 82 | 0.150 |
Why?
| Emergency Service, Hospital | 1 | 2017 | 335 | 0.150 |
Why?
| Diet Surveys | 1 | 2013 | 15 | 0.150 |
Why?
| Lymphoma, Follicular | 1 | 2013 | 63 | 0.140 |
Why?
| Socioeconomic Factors | 2 | 2017 | 492 | 0.140 |
Why?
| Pregnancy | 2 | 2016 | 2466 | 0.140 |
Why?
| Adaptation, Physiological | 1 | 2015 | 285 | 0.140 |
Why?
| Factor Analysis, Statistical | 1 | 2013 | 93 | 0.140 |
Why?
| Nebraska | 1 | 2012 | 13 | 0.140 |
Why?
| Matrix Metalloproteinases | 1 | 2012 | 28 | 0.140 |
Why?
| Vitamin B 6 | 1 | 2012 | 3 | 0.140 |
Why?
| Erythrocyte Membrane | 1 | 2012 | 61 | 0.140 |
Why?
| Survival Analysis | 2 | 2014 | 1482 | 0.140 |
Why?
| Environment Design | 1 | 2012 | 11 | 0.130 |
Why?
| Intestines | 1 | 2015 | 386 | 0.130 |
Why?
| Cause of Death | 1 | 2013 | 254 | 0.130 |
Why?
| Genistein | 1 | 2011 | 16 | 0.130 |
Why?
| Age Factors | 2 | 2014 | 1753 | 0.130 |
Why?
| Child, Preschool | 2 | 2019 | 3389 | 0.130 |
Why?
| Nipple Aspirate Fluid | 1 | 2011 | 1 | 0.130 |
Why?
| Estrone | 1 | 2011 | 10 | 0.130 |
Why?
| Soybean Proteins | 1 | 2011 | 6 | 0.130 |
Why?
| Continental Population Groups | 1 | 2014 | 265 | 0.130 |
Why?
| Geography | 1 | 2012 | 198 | 0.130 |
Why?
| Cataract | 1 | 2011 | 67 | 0.120 |
Why?
| Dietary Sucrose | 1 | 2010 | 13 | 0.120 |
Why?
| Urinary Bladder Neoplasms | 1 | 2013 | 262 | 0.120 |
Why?
| Estradiol | 1 | 2011 | 251 | 0.120 |
Why?
| Internship and Residency | 4 | 2019 | 780 | 0.110 |
Why?
| Hypertension | 1 | 2019 | 1130 | 0.110 |
Why?
| Databases, Factual | 1 | 2013 | 727 | 0.110 |
Why?
| Los Angeles | 3 | 2013 | 22 | 0.110 |
Why?
| Diabetes Mellitus | 1 | 2015 | 647 | 0.100 |
Why?
| Attitude to Health | 1 | 2010 | 213 | 0.100 |
Why?
| Neoplasm Staging | 1 | 2013 | 1806 | 0.090 |
Why?
| Residence Characteristics | 2 | 2019 | 155 | 0.090 |
Why?
| Exercise | 3 | 2016 | 222 | 0.090 |
Why?
| Ovarian Neoplasms | 1 | 2011 | 581 | 0.090 |
Why?
| Prognosis | 1 | 2013 | 3279 | 0.080 |
Why?
| Decision Making | 1 | 2010 | 565 | 0.080 |
Why?
| Genetic Variation | 1 | 2012 | 1290 | 0.080 |
Why?
| Cross-Over Studies | 2 | 2017 | 372 | 0.070 |
Why?
| Severity of Illness Index | 2 | 2020 | 1582 | 0.070 |
Why?
| Genetic Predisposition to Disease | 1 | 2011 | 2005 | 0.070 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1131 | 0.070 |
Why?
| Antineoplastic Agents | 1 | 2013 | 2190 | 0.060 |
Why?
| Predictive Value of Tests | 2 | 2019 | 1519 | 0.060 |
Why?
| Elastic Tissue | 1 | 2019 | 18 | 0.060 |
Why?
| Meglumine | 1 | 2019 | 35 | 0.060 |
Why?
| Autopsy | 1 | 2019 | 95 | 0.050 |
Why?
| Polysomnography | 1 | 2020 | 172 | 0.050 |
Why?
| Oxygen Consumption | 1 | 2020 | 227 | 0.050 |
Why?
| Organometallic Compounds | 1 | 2019 | 121 | 0.050 |
Why?
| Poverty Areas | 1 | 2018 | 29 | 0.050 |
Why?
| Computers, Handheld | 1 | 2018 | 35 | 0.050 |
Why?
| Artifacts | 1 | 2019 | 221 | 0.050 |
Why?
| Social Work | 1 | 2017 | 13 | 0.050 |
Why?
| Dairy Products | 1 | 2016 | 2 | 0.050 |
Why?
| Video Recording | 1 | 2018 | 170 | 0.050 |
Why?
| Mexico | 1 | 2016 | 57 | 0.050 |
Why?
| Attitude | 1 | 2017 | 98 | 0.050 |
Why?
| Patient Preference | 1 | 2017 | 86 | 0.040 |
Why?
| Vaccination | 1 | 2017 | 165 | 0.040 |
Why?
| Animals | 2 | 2015 | 25007 | 0.040 |
Why?
| Deoxyguanosine | 1 | 2016 | 27 | 0.040 |
Why?
| China | 1 | 2016 | 202 | 0.040 |
Why?
| Teaching | 1 | 2017 | 136 | 0.040 |
Why?
| Program Evaluation | 1 | 2017 | 270 | 0.040 |
Why?
| Cecum | 1 | 2015 | 70 | 0.040 |
Why?
| Croatia | 1 | 2015 | 1 | 0.040 |
Why?
| Urban Population | 1 | 2017 | 203 | 0.040 |
Why?
| Biopsy | 1 | 2019 | 1074 | 0.040 |
Why?
| Pilot Projects | 1 | 2017 | 719 | 0.040 |
Why?
| Ileum | 1 | 2015 | 157 | 0.040 |
Why?
| Survival Rate | 1 | 2019 | 1764 | 0.040 |
Why?
| Weight Gain | 1 | 2015 | 117 | 0.040 |
Why?
| Neoplasm Grading | 1 | 2016 | 284 | 0.040 |
Why?
| Disease Progression | 1 | 2019 | 1315 | 0.040 |
Why?
| Digestive System Surgical Procedures | 1 | 2015 | 109 | 0.040 |
Why?
| Treatment Outcome | 2 | 2019 | 6826 | 0.040 |
Why?
| Electronic Health Records | 1 | 2017 | 210 | 0.040 |
Why?
| Body Fat Distribution | 1 | 2014 | 12 | 0.040 |
Why?
| Primary Health Care | 1 | 2017 | 232 | 0.040 |
Why?
| Energy Metabolism | 1 | 2015 | 231 | 0.040 |
Why?
| Contrast Media | 1 | 2019 | 982 | 0.040 |
Why?
| Sex Factors | 1 | 2017 | 1002 | 0.040 |
Why?
| Xanthophylls | 1 | 2013 | 2 | 0.040 |
Why?
| beta Carotene | 1 | 2013 | 4 | 0.040 |
Why?
| Regression Analysis | 1 | 2015 | 604 | 0.040 |
Why?
| Micronutrients | 1 | 2013 | 12 | 0.040 |
Why?
| Dietary Carbohydrates | 1 | 2013 | 36 | 0.040 |
Why?
| Dietary Proteins | 1 | 2013 | 33 | 0.040 |
Why?
| Australia | 1 | 2013 | 77 | 0.040 |
Why?
| Maintenance Chemotherapy | 1 | 2013 | 62 | 0.040 |
Why?
| Vitamin E | 1 | 2013 | 35 | 0.040 |
Why?
| Folic Acid | 1 | 2013 | 45 | 0.040 |
Why?
| Matrix Metalloproteinase 7 | 1 | 2012 | 9 | 0.040 |
Why?
| Matrix Metalloproteinase 3 | 1 | 2012 | 8 | 0.040 |
Why?
| Matrix Metalloproteinase 1 | 1 | 2012 | 16 | 0.040 |
Why?
| Polymerase Chain Reaction | 1 | 2016 | 971 | 0.030 |
Why?
| Oxidative Stress | 1 | 2016 | 368 | 0.030 |
Why?
| Oleic Acid | 1 | 2012 | 16 | 0.030 |
Why?
| Phenotype | 1 | 2019 | 2054 | 0.030 |
Why?
| Arylamine N-Acetyltransferase | 1 | 2012 | 9 | 0.030 |
Why?
| Mutagens | 1 | 2012 | 29 | 0.030 |
Why?
| Interleukin-6 | 1 | 2014 | 209 | 0.030 |
Why?
| Sleep | 1 | 2017 | 376 | 0.030 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2012 | 42 | 0.030 |
Why?
| Physical Exertion | 1 | 2012 | 37 | 0.030 |
Why?
| Quinoxalines | 1 | 2012 | 52 | 0.030 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2013 | 313 | 0.030 |
Why?
| Confidence Intervals | 1 | 2012 | 228 | 0.030 |
Why?
| Antioxidants | 1 | 2013 | 219 | 0.030 |
Why?
| Cholesterol, HDL | 1 | 2012 | 165 | 0.030 |
Why?
| Triglycerides | 1 | 2012 | 249 | 0.030 |
Why?
| Radioimmunoassay | 1 | 2011 | 159 | 0.030 |
Why?
| Premenopause | 1 | 2011 | 48 | 0.030 |
Why?
| Drug Administration Schedule | 1 | 2013 | 921 | 0.030 |
Why?
| Isoenzymes | 1 | 2012 | 271 | 0.030 |
Why?
| Sex Distribution | 1 | 2011 | 163 | 0.030 |
Why?
| Japan | 1 | 2011 | 285 | 0.030 |
Why?
| Neoplasm Invasiveness | 1 | 2012 | 500 | 0.030 |
Why?
| Ultraviolet Rays | 1 | 2011 | 188 | 0.030 |
Why?
| Cholesterol | 1 | 2012 | 377 | 0.030 |
Why?
| Lipids | 1 | 2012 | 337 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 651 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2012 | 975 | 0.030 |
Why?
| Vitamin D | 1 | 2011 | 234 | 0.030 |
Why?
| Tomography, X-Ray Computed | 1 | 2019 | 2367 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2015 | 2916 | 0.030 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2012 | 744 | 0.030 |
Why?
| Inflammation | 1 | 2013 | 713 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2013 | 1078 | 0.020 |
Why?
| Mice | 1 | 2015 | 10276 | 0.020 |
Why?
|
|
Ollberding's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Physical Neighbors  People whose addresses are nearby this person. _
|